Literature DB >> 18441722

Pregnancy outcome in women with psoriasis.

Gila Ben-David1, Eyal Sheiner, Mordechai Hallak, Amalia Levy.   

Abstract

OBJECTIVE: To determine pregnancy outcome in women with psoriasis. STUDY
DESIGN: A case-control study of 145 deliveries in women with psoriasis during the years 1988-2004 was performed. For every birth, 6 births to nonpsoriatic women (n=860) were randomly selected and adjusted for ethnicity and year of delivery.
RESULTS: Recurrent abortions (OR = 2.1, 95% CI 1.1-4.9, p = 0.04) and chronic hypertension (OR = 2.9, 95% CI 1.01-8.3, p= 0.048) were significantly associated with psoriasis in a multivariable analysis with backward elimination. Psoriasis was also found as an independent risk factor for cesarean delivery (CD) in another multivariable analysis with CD as the outcome variable (OR = 4.1, 95% CI 2.3-7.5, p < 0.001).
CONCLUSION: A significant association exists between psoriasis and pregnancy complications. Moreover, psoriasis is an independent risk factor for CD. Thus, physicians should keep in mind that psoriasis might have nondermatologic implications that may adversely affect pregnancy.

Entities:  

Mesh:

Year:  2008        PMID: 18441722

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  11 in total

1.  No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis.

Authors:  Elise Harder; Anne-Marie Nybo Andersen; Mads Kamper-Jørgensen; Lone Skov
Journal:  J Invest Dermatol       Date:  2014-01-24       Impact factor: 8.551

Review 2.  Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review.

Authors:  Javier P Gisbert; María Chaparro
Journal:  Drugs       Date:  2020-07       Impact factor: 9.546

3.  [Psoriasis therapy in pregnancy : Consultation of pregnant patients].

Authors:  B Stephan; M A Radtke; M Augustin
Journal:  Hautarzt       Date:  2019-12       Impact factor: 0.751

Review 4.  Oversight and Management of Women with Psoriasis in Childbearing Age.

Authors:  Ștefana Bucur; Alexandra-Petruța Savu; Ana Maria Alexandra Stănescu; Elena-Daniela Șerban; Alin-Codruț Nicolescu; Traian Constantin; Anca Bobircă; Maria-Magdalena Constantin
Journal:  Medicina (Kaunas)       Date:  2022-06-09       Impact factor: 2.948

5.  Spontaneous abortion during ustekinumab therapy.

Authors:  Christina Fotiadou; Elizabeth Lazaridou; Eleni Sotiriou; Demetrios Ioannides
Journal:  J Dermatol Case Rep       Date:  2012-12-31

6.  Pregnancy outcomes, fertility, and family planning in women with psoriatic arthritis.

Authors:  Amanda M Eudy; Gary McDaniel; Megan Eb Clowse
Journal:  Obstet Med       Date:  2019-01-31

Review 7.  Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?

Authors:  Katja Woidacki; Ana Claudia Zenclussen; Frank Siebenhaar
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

Review 8.  Update on biologic safety for patients with psoriasis during pregnancy.

Authors:  Martina L Porter; Stephen J Lockwood; Alexa B Kimball
Journal:  Int J Womens Dermatol       Date:  2017-02-04

9.  Pregnancy After Tubal Sterilization in a Woman Treated with Biologics for Severe Psoriasis.

Authors:  Charlée Nardin; Morgane Colas; Vincent Curie; Fabien Pelletier; Eve Puzenat; François Aubin
Journal:  Dermatol Ther (Heidelb)       Date:  2018-03-09

Review 10.  Psoriasis in pregnancy: challenges and solutions.

Authors:  Gino Antonio Vena; Nicoletta Cassano; Gilberto Bellia; Delia Colombo
Journal:  Psoriasis (Auckl)       Date:  2015-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.